An extensive outbreak of a toxicologic disease in dogs, designated "Hepatitis X", was first reported in the southeastern United States in 19521. Subsequent investigations2 traced the cause to commercial dog food which contained peanut meal as the principal protein source. A relationship was also established between this syndrome in dogs and "moldy corn poisoning" in swine33 4. Sporadic outbreaks of both diseases continue to occur and physiologically active substances have now been isolated from suspected feeds.
The outbreak of a disease in turlieys in England5 in 1960 resulted in the loss of over 100,000 poults and served to focus attention on a serious toxicologic problem. The disease was subsequently reported in turkeys and in other species6 from other countries?. This initiated a series of investigations which led to the isolation and chemical identification of the etiologic agents8. The biological activity, associated with a group of toxic compounds elaborated by some strains of Aspergdh-$avm, was contained in peanut meal which was included as a protein source in the feed. Partially purified preparations of the compounds, referred to as aflatoxins, and purified fractions* thereof are potent hepatotoxins for several species of animals and carcinogenic for some othersg. 10,11. Recent findings of N E W B E R N E~~ have shown conclusively that during the past several years much of the feedgrade peanut meal purchased on the open market in the United States has been contaminated with aflatoxins. Subsequent action by the U.S. Food and Drug Administration and the food industry has assured consumers that edible peanuts and peanut products will be carefully screened for these toxins. Since many of the outbreaks of hepatitis X in dogs in past years were associated with commercial feeds which contained peanut meal, the work reported here was initiated to study the effect of aflatoxin B1 in dogs and to compare the experimental disease with spontaneous hepatitis X observed in field cases. (Table I) were housed in steel cages in temperature-controlled quarters. They were fed experimental diets or a commercially prepared dog food twice daily and water was supplied ad libitum. Three animals (D-1, D-2, and D-3) were fed a commercial dog food obtained from two field cases in which it was implicated as the cause of toxicity. 'These samples were subjected to a chemical assay for aflatoxin" and were found to contain aflatoxin B1 only, at concentrations of 0.5 ppm and 1.75 ppm. These toxic feed samples were fed without further modification.
Materials and Methods

Dogs of both sexes and various ages
Aflatoxin preparations were administered in two forms. Dogs D-4 and D-5 received multiple doses of a partially purified aflatoxin concentrate containing aflatoxins BI (35%) and GI (15%). 'This preparation (crude aflatoxin) was dispersed on casein and administered to the animals by capsule. All of the remaining animals received a highly purified preparation of aflatoxin Bj which was administered either orally in crystalline form (by capsule) or dissolved in dimethylsulfoxide (DMSO) for intraperitoneal injection. Appropriate solvent controls were included as indicated in Table I . Tissues were taken for histologic studies from all animals at the time of sacrifice or as soon as possible after death.
Results
In all of the various treatment groups, clinical evidence of toxi-city was limited to anorexia, weight loss and icterus. Animals receiving aflatoxin B1 often showed no overt symptoms, frequently appearing normal in the evening but found dead the following morning.
Three animals fed toxic commercial feed were killed after 35 days and were found to have developed minimal to moderate hepatic lesions. On the basis of the estimated aflatoxin intake of these animals, two dogs were dosed daily with partially purified aflatoxin mixture. Lesions similar to those induced by toxic feed were caused by 30 doses of 0.2 mg/day (total aflatoxin dose approximately 0.1 mg/day). When this dosage was increased (Dog D-5), the animal died on the 17th day of treatment, with moderate hepatic lesions.
These preliminary observations led to a more systematic study of the effects of purified aflatoxin B1. A single oral dose of 0.5 mg/lig resulted in no deaths. However, in a group of 5 animals (Dogs 1-5, Table I ) killed from 2-14 days after dosing, all developed liver lesions which were clearly apparent within 3 days, and showed only minimal regression up to 14 days later.
Repeated oral administration of smaller doses of aflatoxin B1 at a level of 0.2 mg/day/animal for 15 days (Dogs 6-9) resulted in no mortality up to 13 days after dosing was discontinued. These animals killed at that time showed moderate to severe liver lesions. One animal of this group was retained and eventually died 20 days after cessation of treatment.
Intraperitoneal injection of aflatoxin B1 at a dose of 1 mg/kg body weight resulted in the death of 2 / 3 animals within 14 days. However, when this amount was administered in two doses with a 4-day interval between treatment, z/3 animals survived up to 9 days, at which time they were killed. All of these animals showed moderate to severe liver lesions.
These results indicate that small repeated doses tended to be less lethal than single larger total doses, and that oral and intraperitoneal exposures were essentially equivalent in effect. It is also evident that the dog is susceptible to the lethal effects of the compound in the same range of doses as some other species, i. e., ducks, guinea pigs and rabbits53 6, 79 12. Lesions were similar to those reported for hepatitis XI? 2. Major findings at autopsy were icterus of mucous and serous membranes, yellowish discoloration of the liver (Fig. l) , edema of the gall bladder ( Fig. a) , ascites and, occasionally, hemorrhage into the gastrointestinal tract. Blood clotting time (capillary pipette) was lengthened by a factor of 10 or more and in two animals clotting did not take place within two hours-the limit of observation.
Microscopically, fatty change ( Fig. 3 ) and bile duct hyperplasia (Figs. 4 & 5) were the most prominent alterations. Fatty change first occurred in the centrolobular zone and spread toward the periphery of the lobule. This was associated with moderate to severe congestion and parenchymal cell necrosis. Bile ductule cell hyperplasia was observed extending to all zones of the lobule and in some cases appeared to be most pronounced in areas away from the portal zone. The more chronic cases tended to proliferate primarily in the periportal zone.
The greatly thickened wall of the gall bladder, observed grossly, was a result of severe sub-serosal edema ( Fig. 6 ) and of marked edema and hemorrhage of the mucosa (Fig. 7) . Lymphoid depletion and necrosis was seen in the thymus, spleen and lymph nodes.
Two females carrying young at the time of exposure to aflatoxin developed severe gross uterine and placental hemorrhage; one had macerated fetuses and mesenteric hemorrhage, the other aborted. Tubular necrosis of the kidney was an inconsistant finding, while congestion and hemorrhage of the adrenal cortex were observed in many of the more acute cases. 
Discussion
This study was initiated to determine the acute effects of aflatoxin B1 in dogs and to compare these findings with those described in natural outbreaks of hepatitis X.
Our results indicate that the dog is highly sensitive to the toxic efiects of aflatoxin. The histologic studies illustrate the remarkable changes induced by aflatoxin in the dog and point out the striking similarity of experimentally iiiduced lesions to those observed in dogs fed toxic feed in our laboratory and in natural outbreaks of hepatitis X. Three dogs given feed from field cases of hepatitis X developed lesions characteristic of those previously described in the literature and similar to our experimentally induced lesions. There was a dose-response relationship to survival time and intensity of histopathologic change but route of administration had little effect. Decrease in survival time and severity of lesions were found to be most marked when aflatoxin B1 was administered in pure form, intraperitoneally or orally, at a high level and in a single dose. Smaller doses given at intervals appeared to allow inactivation and/or excretion of larger total doses.
There was some indication that the oral route of administration of the purified toxin, compared to the intraperitoneal route, resulted in a quicker response, particularly at higher doses; but this may have been more apparent than real. There could be little doubt, however, that absorption from the gastrointestinal tract was very rapid and that it approximated speed of absorption from the peritoneal cavity.
It is important to note that while the similarities between experimentally induced aflatoxicity and field cases of hepatitis X are striking and significant, there are some differences. In hepatitis X, all reported cases displayed icterus and bile duct proliferation. In our work, while these lesions were commonly present, they were not constant findings. This may have been due to the acute nature of our studies without suacient time for full-blown manifestation; indeed, these changes were more marked in animals surviving for longer periods. In addition, the experimental kidney alterations noted here were less prominent than those observed in hepatitis X. On the other hand, we observed congestion and/or hemorrhage of the inner cortex of the adrenal gland, a lesion unreported in hepatitis X.
There is general agreement on the association of hepatitis X and moldy feeds, but it is unliltely that the disease results from a single toxic factor. It is more probable that the disease results from a combination of more than one mycotoxin and that the variable symptoms and lesions are a consequence of different types and amounts of such toxins present in contaminated f:-eds.
Some interesting additional effects of aflatoxin were observed and deserve further study. Jntraperitoneal administration of aflatoxin evoked abortion and/or death of the fetuses. This may have been the direct effect of aflatoxin on the fetus or it could have resulted from placental hemorrhage. It should be noted that both pregnant animals in this series were injected with the toxin and direct contact of toxin and gravid uterus must be considered. Failure or delay of normal blood clotting was frequently observed. This may have been a result of liver damage with secondary hypoprothrombinemia. If this were the case, however, the system was depleted of prothrombin in a shorter period of time than one would expect even under the extreme conditions of our experiment. A defect in any of the numerous factors involved in blood clotting could account for the hemorrhages in the pregnant females.
Symptoms and lesions observed in dogs in controlled experiments with purified aflatoxin were similar in many respects to those described in field cases of hepatitis X. Although conclusive evidence is lacking, our results strongly suggest that hepatitis X and experimental aflatoxin poisoning in the dog are the same disease. The outbreaks of hepatitis X are believed to have been caused by mold by-products contained in the dog food. The work of BAILEY and G R O T H~ and results of our experimental studies support this view but further work is needed to clarify the exact relationship.
This work is a study of the acute effects of aflatoxin BI in dogs. The dog has a remarkable susceptibility to aflatoxin B1 given by oral and intraperitoneal routes.
Intraperitoneal administration resulted in the shortest survival time and the most profound pathological changes. However, massive single oral doses produced lesions of similar nature and intensity. Oral administration of aflatoxin in small, divided doses, over extended periods proved to be less toxic. The experimentally induced disease resembled hepatitis X in many respects.
Es wird die akute Wirlcung von Aflatoxin BI bei Hunden mittels zweier Applilcationswege untersucht. Dabei wurde gefunden, dass der Hund bei oraler und intraperitonealer Verabreichung sehr empfindlich gegeniiber Aflatoxin BI ist. Die Intraperitonealgabe bewirkte die kiirzeste Uberlebenszeit und starksten pathologischen Veranderungen, jedoch verursachten massive orale Dosen fast ebenso starke Schadigungen. Bei peroraler Applilcation in kleinen, iiber einen langeren Zeitraum verteilten Dosen erwies sich Aflatoxin als weniger toxisch. Die experimentell herbeigefiihrte I<rankheit glich in vieler Hinsicht der Hepatitis X.
